Saltar al contenido

AbbVie Inc. (ABBV) stock: revenue, earnings & dividend

AbbVie Inc. (ABBV, NYSE): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener ABBV · NYSE Pharma & Biotech US-IL

Key figures

Fiscal year
2025
Revenue
61.2 bn $
Revenue growth
8.6 %
Revenue growth 5y (p.a.)
6 %
Net income
4.23 bn $
Net margin
6.9 %
Operating margin
24.7 %
Earnings per share (diluted)
2.36 $
Dividend per share
6.65 $
Payout ratio
281.8 %
Consecutive dividend years
13 years
Consecutive dividend raises
12 years
Dividend growth 5y (p.a.)
6.6 %
Total assets
134 bn $
Equity
-3.27 bn $
Equity ratio
-2.4 %
Return on equity
–
Cash
5.23 bn $
Operating cash flow
19 bn $
Free cash flow
17.8 bn $
Shares outstanding
1,767,616,306

History

Revenue by fiscal year

2016 25.6 bn $
2017 28.2 bn $
2018 32.8 bn $
2019 33.3 bn $
2020 45.8 bn $
2021 56.2 bn $
2022 58.1 bn $
2023 54.3 bn $
2024 56.3 bn $
2025 61.2 bn $

Net income by fiscal year

2016 5.95 bn $
2017 5.31 bn $
2018 5.69 bn $
2019 7.88 bn $
2020 4.62 bn $
2021 11.5 bn $
2022 11.8 bn $
2023 4.86 bn $
2024 4.28 bn $
2025 4.23 bn $

Dividend per share

2016 2.35 $
2017 2.63 $
2018 3.95 $
2019 4.39 $
2020 4.84 $
2021 5.31 $
2022 5.71 $
2023 5.99 $
2024 6.29 $
2025 6.65 $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
202561.2 bn $4.23 bn $2.36 $6.65 $19 bn $
202456.3 bn $4.28 bn $2.39 $6.29 $18.8 bn $
202354.3 bn $4.86 bn $2.72 $5.99 $22.8 bn $
202258.1 bn $11.8 bn $6.63 $5.71 $24.9 bn $
202156.2 bn $11.5 bn $6.45 $5.31 $22.8 bn $
202045.8 bn $4.62 bn $2.72 $4.84 $17.6 bn $
201933.3 bn $7.88 bn $5.28 $4.39 $13.3 bn $
201832.8 bn $5.69 bn $3.66 $3.95 $13.4 bn $
201728.2 bn $5.31 bn $3.30 $2.63 $9.96 bn $
201625.6 bn $5.95 bn $3.63 $2.35 $–

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)